Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Is the treatment of multiple sclerosis headed in the wrong direction?
Fingolimod protects cultured cortical neurons against excitotoxic death.
Vitamin B(12) Deficiency and Multiple Sclerosis; Is there Any Association?
Effects of Topiramate on Dysaesthetic Pain in a Patient with Multiple Sclerosis.
Hematopoietic stem cell transplantation for multiple sclerosis: is it a clinical reality?
Delta-9-tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial.
ATP increases the migration of microglia across the brain endothelial cell monolayer.
Spasticity: pathophysiology, evaluation and management.
Severe disease reactivation in four patients with relapsing-remitting multiple sclerosis after fingolimod cessation.
Physical fitness assessment in multiple sclerosis patients: A controlled study.
Metabotropic glutamate receptor type 1 autoimmunity: Clinical features and treatment outcomes.
Targeting the shift from m1 to m2 macrophages in experimental autoimmune encephalomyelitis mice treated with fasudil.
Treatment of optic neuritis by plasma exchange (add-on) in neuromyelitis optica.
Cutting Edge: TNF Receptor-Associated Factor 4 Restricts IL-17-Mediated Pathology and Signaling Processes.
A rare case of mixed connective tissue disease complicated with neuromyelitis optica.
Validation and interpretation of the Dutch version of the Multiple Sclerosis Neuropsychological Screening Questionnaire.
Shape Analysis of the Corpus Callosum and Cerebellum in Female MS Patients with Different Clinical Phenotypes.
Sexual Behavior, Body Image, and Partnership in Chronic Illness: A Comparison of Huntington's Disease and Multiple Sclerosis.
Treatment with MOG-DNA vaccines induces CD4+CD25+FoxP3+ regulatory T cells and upregulates genes with neuroprotective functions in experimental autoimmune encephalomyelitis.
Fingolimod treatment promotes regulatory phenotype and function of B cells.
Neuroaxonal regeneration is more pronounced in early multiple sclerosis than in traumatic brain injury lesions.
FTY720 Impairs Mucosal Immunity and Clearance of the Enteric Pathogen Citrobacter rodentium.
Increasing age at disability milestones among MS patients in the MSBase Registry.
Kinin-mediated inflammation in neurodegenerative disorders.
Biologically plausible and evidence-based risk intervals in immunization safety research.
Pages
« first
‹ previous
…
172
173
174
175
176
177
178
179
180
…
next ›
last »